Chronic Obstructive Pulmonary Disease Drugs Market Opportunity and Forecast to 2020
Chronic Obstructive Pulmonary Disease Drugs Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
(EMAILWIRE.COM, November 23, 2017 ) COPD is a chronic disease condition with a combination of symptoms of both chronic bronchitis and emphysema. Chronic bronchitis results in inflammation in the bronchioles, which results in increased mucus production. The condition is usually associated with a long-term cough with mucus. Emphysema results in the destruction of the walls of the alveoli, resulting in difficulty in breathing.
Analysts forecast the global chronic obstructive pulmonary disease (COPD) drugs market to grow at a CAGR of 4.85% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat COPD.
Request sample copy @ http://www.reportsweb.com/inquiry&RW0001332793/sample
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Key vendors
-AstraZeneca
-Boehringer Ingelheim
-GSK
-Merck
-Novartis
-Teva
Other prominent vendors
-Ache Laboratorios Farmaceuticos
-Almirall
-Aquinox Pharmaceuticals
-Ario Pharma
-Asmacure
-Astellas Pharma
-BioMarck Pharmaceuticals
-Chiesi Farmaceutici
-Cytokinetics
-F. Hoffmann-La Roche
Have any query? Enquire about report @ http://www.reportsweb.com/inquiry&RW0001332793/buying
Market driver
-Increase in smoking prevalence
-Uptake of LABA/LAMA combination therapies
-Robust pipeline with tentative approval of drugs
Market challenge
-Lack of innovation in pipeline molecules
-Negligence toward use of controller medications
-Low diagnosis rates
Market trend
-Innovative technologies for drug delivery
-Increased adoption of e-cigarettes and smoking cessation products
-Emergence of ultrasonic nebulizers
-Increase in online marketing services
-Growing use of home healthcare devices
Fundamentals of Table of Content:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Global construction market
PART 06: Market drivers
PART 07: Market trends
PART 08: Global AEC market
PART 09: Market segmentation by product
PART 10: Geographical segmentation
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Five forces model
PART 14: Key vendor analysis
PART 15: Key vendor profiles
Browse complete report @ http://www.reportsweb.com/global-chronic-obstructive-pulmonary-disease-drugs-market-2016-2020
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Analysts forecast the global chronic obstructive pulmonary disease (COPD) drugs market to grow at a CAGR of 4.85% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat COPD.
Request sample copy @ http://www.reportsweb.com/inquiry&RW0001332793/sample
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Key vendors
-AstraZeneca
-Boehringer Ingelheim
-GSK
-Merck
-Novartis
-Teva
Other prominent vendors
-Ache Laboratorios Farmaceuticos
-Almirall
-Aquinox Pharmaceuticals
-Ario Pharma
-Asmacure
-Astellas Pharma
-BioMarck Pharmaceuticals
-Chiesi Farmaceutici
-Cytokinetics
-F. Hoffmann-La Roche
Have any query? Enquire about report @ http://www.reportsweb.com/inquiry&RW0001332793/buying
Market driver
-Increase in smoking prevalence
-Uptake of LABA/LAMA combination therapies
-Robust pipeline with tentative approval of drugs
Market challenge
-Lack of innovation in pipeline molecules
-Negligence toward use of controller medications
-Low diagnosis rates
Market trend
-Innovative technologies for drug delivery
-Increased adoption of e-cigarettes and smoking cessation products
-Emergence of ultrasonic nebulizers
-Increase in online marketing services
-Growing use of home healthcare devices
Fundamentals of Table of Content:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Global construction market
PART 06: Market drivers
PART 07: Market trends
PART 08: Global AEC market
PART 09: Market segmentation by product
PART 10: Geographical segmentation
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Five forces model
PART 14: Key vendor analysis
PART 15: Key vendor profiles
Browse complete report @ http://www.reportsweb.com/global-chronic-obstructive-pulmonary-disease-drugs-market-2016-2020
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results